Asklepios BioPharmaceutical (AskBio)

Research Triangle, NC · San Sebastian, ES
Find alternatives to Asklepios BioPharmaceutical (AskBio) for AAV →
Hybrid — also manufactures internal programs
AAV
10 confirmed programs · 4 sponsors · Last scored 2026-10-29
61.8
Signal Score
○ FDA Inspections ✓ Clinical Trials (10) ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Asklepios BioPharmaceutical (AskBio)

Signal Score
61.8/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Research Triangle, NC · San Sebastian, ES
Modalities
AAV
Active Programs
10 confirmed from ClinicalTrials.gov across 4 sponsors
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Asklepios BioPharmaceutical (AskBio)

Hybrid developer + CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations 60.0
10 active programs across 4 sponsors
Modalities: AAV
5 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
10 active programs across 4 sponsors · Modalities: AAV · 5 programs in advanced phases (Phase 2/3)
Programs 10
Sponsors4
ModalitiesAAV
10 active programs across 4 sponsors
Modalities: AAV
5 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT07566429 A Study of AB-1005 Gene Therapy in Japanese Adults With... PHASE2 Not Yet Recruiting
NCT07282847 A Study to Evaluate Safety, Tolerability, and Efficacy of... PHASE1/PHASE2 Recruiting
NCT07081841 AB-1005 Long-Term Follow-up Study NA Enrolling By Invitation
NCT06285643 A Study of AAV2-GDNF in Adults With Moderate Parkinson's... PHASE2 Recruiting
NCT05598333 Phosphatase Inhibition by Intracoronary Gene Therapy in... PHASE2 Active Not Recruiting
NCT05230459 A Study to Evaluate the Safety of AB-1003 (Previously... PHASE1/PHASE2 Active Not Recruiting
NCT05699460 Pre-Gene Therapy Study in Parkinson's Disease and Multiple... NA Completed
NCT04167540 GDNF Gene Therapy for Parkinson's Disease PHASE1 Active Not Recruiting
NCT03533673 AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease PHASE1 Completed
NCT00428935 Safety Study of Mini-dystrophin Gene to Treat Duchenne... PHASE1 Completed
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Financial Stability 68.0
Parent company: Bayer
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Bayer
Financial assessment: 68.0/100
Capacity 58.0
2 manufacturing sites
Sites: Research Triangle, NC, San Sebastian, ES
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
2 manufacturing sites

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business (4 postings on Nov 20, 2026), and we can't yet tell which of those roles belong to it. Why: the careers board covers the gene-therapy biotech, not its manufacturing arm. We'd rather show no number than one that isn't really this company's.
Source: askbio.wd12.myworkdayjobs.com · Checked Nov 20, 2026

Frequently Asked Questions About Asklepios BioPharmaceutical (AskBio)

How many clinical programs is Asklepios BioPharmaceutical (AskBio) linked to?
Asklepios BioPharmaceutical (AskBio) is associated with 10 clinical trials in CDMO Signal's ClinicalTrials.gov-sourced data.
What is Asklepios BioPharmaceutical (AskBio)'s CDMO Signal Score?
Asklepios BioPharmaceutical (AskBio) has a Signal Score of 62/100, based on quality, operations, financial stability, and capacity data.
Evaluating Asklepios BioPharmaceutical (AskBio) for a manufacturing program?
Use the free AI matchmaker to compare Asklepios BioPharmaceutical (AskBio) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs →

Similar CDMOs

Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Takeda
Boston, MA · Zurich, CH
Signal Score: 83.4
AAV, Cell Therapy

Compare Asklepios BioPharmaceutical (AskBio) with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Asklepios BioPharmaceutical (AskBio)
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.